Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 160,560 - -
Change - -20.69% -0.18% 2.67% 11.05% -26.3% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 172,249 169,417 165,519
Change - -20.41% 0.28% 1.92% 9.66% -22.5% -1.64% -2.3%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 22.8x 19.5x 17x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.25x 3.11x 2.9x
PEG - -36.9x -2x 0x -0.7x 2.62x 1.1x 1.1x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.19x 2.93x 2.74x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.43x 3.09x 2.82x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 12.9x 11.6x 10.4x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 14.8x 13x 11.5x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 19.9x 18x 15.9x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 5.03% 5.56% 6.27%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.547 2.715 2.866
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.76% 2.95% 3.11%
EPS 2 3.94 3.91 3.26 7.64 3.72 4.043 4.736 5.437
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 63% 57.3% 52.7%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,257 54,749 58,634
EBITDA 1 12,815 12,485 10,188 10,635 11,735 13,388 14,551 15,928
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,665 13,038 14,362
Net income 1 7,071 6,933 5,723 13,402 6,524 7,018 8,389 9,226
Net Debt 1 7,801 6,891 7,783 6,509 4,407 11,689 8,857 4,959
Reference price 2 140.74 109.79 110.07 113.11 125.29 92.18 92.18 92.18
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 22/01/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
17.73x3.13x11.01x3.79% 101B
15.56x0.18x11.17x0.84% 56.12B
32.8x7.97x20.83x1.22% 53.35B
37.71x3x10.3x2.54% 42.13B
37.76x1.38x12.13x0.21% 35.29B
27.52x4.9x15.61x-.--% 26.57B
42.63x7.39x26.67x0.25% 25.79B
23.17x3.39x12.19x1.25% 20.69B
19.74x2.73x10.61x1.6% 19.59B
Average 28.29x 3.78x 14.50x 1.3% 42.32B
Weighted average by Cap. 26.35x 3.60x 13.86x 1.77%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABL Stock
  5. Valuation Abbott Laboratories